Brevan Howard Capital Management’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.84M Buy
9,013
+856
+10% +$270K 0.02% 576
2026
Q1
$2.68M Buy
8,157
+1,376
+20% +$494K 0.02% 445
2025
Q4
$2.38M Sell
6,781
-86
-1% -$31.3K 0.03% 433
2025
Q3
$2.54M Sell
6,867
-26,003
-79% -$10M 0.01% 461
2025
Q2
$13M Buy
+32,870
New +$12.3M 0.08% 136
2024
Q4
– Sell
-2,679
Closed -$968K – 1417
2024
Q3
$968K Buy
+2,679
New +$925K 0.01% 462
2024
Q2
– Sell
-1,729
Closed -$619K – 1384
2024
Q1
$619K Sell
1,729
-137
-7% -$46.1K 0.01% 390
2023
Q4
$559K Buy
+1,866
New +$524K 0.01% 431

Other funds holding SYK

Brevan Howard Capital Management's SYK Position: Q2 2026 in Review

Brevan Howard Capital Management increased its Stryker (SYK) stake by 10% in Q2 2026, buying an estimated $270K and bringing the position to 9,013 shares worth $2.84M. The position accounts for 0.02% of the portfolio, ranked #576.

Brevan Howard Capital Management first reported a position in SYK in Q4 2023 and has held it in 8 quarters since. The position peaked at $13M in Q2 2025. 2,267 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • Brevan Howard Capital Management held 9,013 shares of Stryker worth $2.84M as of Q2 2026.
  • Brevan Howard Capital Management bought 856 Stryker shares in Q2 2026, an estimated $270K.
  • Stryker made up 0.02% of Brevan Howard Capital Management's portfolio in Q2 2026, its #576 holding.
  • Brevan Howard Capital Management first reported a position in Stryker in Q4 2023 and has held it in 8 quarters since.
  • Brevan Howard Capital Management's Stryker position peaked at $13M in Q2 2025.
  • 2,267 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.